Search
for
Sort by
Research 31–60 of 530
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Alopecia areata
- New drugs under investigation for the treatment of alopecias
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- The Role of Janus Kinase Inhibitors in Dermatology
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Role and Mechanisms of Phytochemicals in Hair Growth and Health
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Autoinmune Alopecia/Alopecia Areata
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Prediction of the Mechanism of Shaoyao Gancao Decoction in the Treatment of Alopecia Areata by Network Pharmacology and Its Preliminary Verification Study
- Alopecia areata – Aktuelles Verständnis und Management
- Vitiligo—Current Treatment Options and Future Perspectives
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis